e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
G. Cinel, N. Kiper, D. Orhan, E. Yalçin, D. Dogru, U. Özçelik, B. Oguz, M. Haliloglu, G. Kale (Ankara, Turkey)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
2350
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Cinel, N. Kiper, D. Orhan, E. Yalçin, D. Dogru, U. Özçelik, B. Oguz, M. Haliloglu, G. Kale (Ankara, Turkey). Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome. Eur Respir J 2013; 42: Suppl. 57, 2350
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Chronic interstitial lung disease in children: diagnosis and treatment
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Primary pulmonary interstitial glycogenosis. Long term outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014
Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Clues in interstitial lung disease in children (chILD)
Source: International Congress 2016 – Paediatric bronchology II
Year: 2016
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
Does the
BTNL2
genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Chronic interstitial lung disease in children
Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology
Year: 2017
Chronic interstitial lung disease in children
Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017
Year: 2018
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept